2.0
Aug 2, 2018
Current employee, more than 1 year
Nueva Delhi
Recommend
CEO approval
Business Outlook
Pros
company is investing in diverse portfolio
Cons
regional leaders are worst , pharma with lack good behaviour and language, similar to third class pharma company